共 50 条
- [1] Efficacy and safety of iron carboxymaltose on chronic fatigue in patients with inflammatory bowel disease: a randomised controlled trial [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S102 - S102
- [5] Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S292 - S292
- [6] A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease:: The ferric carboxymaltose (FERINJECT®) randomized controlled trial [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1182 - 1192
- [8] Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (07): : 826 - 834
- [9] Safety and efficacy of ferric carboxymaltose (FCM) for the treatment of iron deficiency anaemia in paediatric patients affected by inflammatory bowel disease (pIBD) [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S337 - S337